These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31112897)

  • 1. Acute psychosis in a polyglot: Linguistic regression to the mother tongue and restoration.
    Saito S
    Asian J Psychiatr; 2019 Jun; 43():91-92. PubMed ID: 31112897
    [No Abstract]   [Full Text] [Related]  

  • 2. Paliperidone-Induced Hyponatremia.
    Tibrewal P; Dhillon R; Sharma J; Bastiampillai T
    Prim Care Companion CNS Disord; 2017 Jul; 19(4):. PubMed ID: 28767207
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone.
    Fu DJ; Turkoz I; Bossie CA; Patel H; Alphs L
    J Affect Disord; 2016 Mar; 193():381-90. PubMed ID: 26802315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral Facial Dystonia (Meige or Brueghel Syndrome) Induced by Paliperidone Palmitate.
    Marques JG
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28129491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of psychotic schizophrenia spectrum disorders in adolescents].
    Popov YV; Yakovleva YA; Pisevich MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):47-50. PubMed ID: 26525621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery outcomes of schizophrenia patients treated with paliperidone palmitate in a community setting: patient and provider perspectives on recovery.
    Williams W; McKinney C; Martinez L; Benson C
    J Med Econ; 2016; 19(5):469-76. PubMed ID: 26671481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Language regression to the mother tongue in polyglot patients with acute psychosis].
    Heinemann F; Assion HJ
    Nervenarzt; 1996 Jul; 67(7):599-601. PubMed ID: 8927199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paliperidone for the treatment of schizoaffective disorder.
    Alphs L; Fu DJ; Turkoz I
    Expert Opin Pharmacother; 2016; 17(6):871-83. PubMed ID: 26934062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study.
    Altamura AC; Delvecchio G; Paletta S; Di Pace C; Reggiori A; Fiorentini A; Mirabile MD; Paoli RA; Cinnante C; Triulzi F; Mauri MC; Brambilla P
    Psychiatry Res Neuroimaging; 2017 Mar; 261():80-84. PubMed ID: 28161644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting paliperidone injection as a treatment option for interictal psychosis of epilepsy: A case report.
    Pinto-Gouveia C; Ventura F; Carneiro M; Mota D; Renca S; Pissarra C
    Psychiatry Clin Neurosci; 2022 Jul; 76(7):347-348. PubMed ID: 35429199
    [No Abstract]   [Full Text] [Related]  

  • 12. Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
    Muthu MS; Sahu AK; Sonali ; Abdulla A; Kaklotar D; Rajesh CV; Singh S; Pandey BL
    Drug Deliv; 2016; 23(1):230-7. PubMed ID: 24853962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric symptoms associated with porphyria: A case report and brief review.
    Santos M; Madhusoodanan S; Kaur K; Brenner R
    Ann Clin Psychiatry; 2017 Aug; 29(3):203-204. PubMed ID: 28738101
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical psychotic symptoms and Dandy-Walker variant.
    Williams AJ; Wang Z; Taylor SF
    Neurocase; 2016 Oct; 22(5):472-475. PubMed ID: 27662527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection.
    Mesones-Peral JE; Gurillo-Muñoz P; Sánchez-Sicilia MP; Miller A; Griñant-Fernández A
    Rev Psiquiatr Salud Ment; 2017; 10(1):33-37. PubMed ID: 27053545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early predictors of a clinical response at 8 weeks in patients with first-episode psychosis treated with paliperidone ER.
    Chung YC; Cui Y; Kim MG; Kim YJ; Lee KH; Chae SW
    J Psychopharmacol; 2016 Aug; 30(8):810-8. PubMed ID: 27334812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with multiple episodes of rhabdomyolysis induced by different neuroleptics.
    Aggarwal R; Guanci N; Marambage K; Caplan JP
    Psychosomatics; 2014; 55(4):404-408. PubMed ID: 24016383
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimated medical cost reductions for paliperidone palmitate vs placebo in a randomized, double-blind relapse-prevention trial of patients with schizoaffective disorder.
    Joshi K; Lin J; Lingohr-Smith M; Fu DJ
    J Med Econ; 2015; 18(8):629-36. PubMed ID: 25800457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.
    Mauri MC; Reggiori A; Paletta S; Di Pace C; Altamura AC
    Expert Opin Drug Saf; 2017 Mar; 16(3):365-379. PubMed ID: 28140680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting psychotic relapse following paliperidone discontinuation.
    Suzuki T
    Lancet Psychiatry; 2023 Mar; 10(3):157-158. PubMed ID: 36804062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.